Amedisys (NASDAQ:AMED) quickly dropped 4.2% after a report that the Dept. of Justice is leaning toward filing a lawsuit to challenge UnitedHealthcare's (UNH) planned acquisition. The regulator ...

Amedisys (AMED) came out with quarterly earnings of $1 per share, missing the Zacks Consensus Estimate of $1.14 per share. This compares to earnings of $0.98 per share a year ago. These figures ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported third-quarter earnings of $16.9 million. The Baton Rouge, Louisiana-based company said it had net ...

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month ...

Amedisys, Inc. is being acquired by UnitedHealth for $3.3 billion, pending DOJ approval, with the stock currently trading below the offer price. The DOJ is scrutinizing the merger due to concerns ...

Amedisys Inc ( (AMED)) has released its Q3 earnings. Here is a breakdown of the information Amedisys Inc presented to its investors. Amedisys, Inc. is a leading healthcare at home company that ...

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Three-Month ...

Amedisys shares have risen roughly 3% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $97.71, a rise of nearly 6% in the last 12 months.

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers next week in a last-ditch effort to persuade the agency not to ...